Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RaPsOdy: CHS-0214 vs Enbrel in Chronic Plaque Psoriasis
2014-000444-14Phase 3Completed
- Sponsor
- Coherus BioSciences, Inc.
- Start
- Aug 2014
- Modality
- Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of GP2015 in plaque psoriasis and psoriasis (2 arms), sponsored by Coherus BioSciences, Inc. Primary endpoints: Primary efficacy endpoint (not specified) and Primary safety endpoint (not specified). Started Aug 2014; status: completed.
02
Drugs
GP2015
03
Conditions
plaque psoriasispsoriasis
Beyond the preview
Go deeper on 2014-000444-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-000444-14.